Literature DB >> 17005603

Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1.

Asad Junaid1, Michael C Moon, Gregory E J Harding, Peter Zahradka.   

Abstract

Osteopontin (OPN) is a secreted phosphoprotein involved in cellular proliferation and associated with tumor progression. Although an intracellular form of OPN has been described, its function remains unknown. In this study, a novel nuclear location for intracellular OPN and a correlation with cell division were demonstrated. OPN distinctly localized to the nucleus in a subset of transiently transfected human embryonic kidney 293 cells. Immunoblotting confirmed the nuclear location of native OPN, and results from immunofluorescence studies suggested an association between nuclear OPN and cell cycle progression. Flow cytometry revealed that nuclear and cellular OPN content rose significantly during the S and G(2)/M phases, respectively. Treatment of cells with the DNA polymerase inhibitor aphidicolin prevented cell cycling and greatly reduced cellular OPN content. The intracellular location of OPN coincided with polo-like kinase-1 (Plk-1), a member of the polo-like kinase family, which, in part through their regulation of centrosome-related events, are integral to successful cellular mitosis. OPN and Plk-1 were coimmunoprecipitated from nuclear, but not cystoslic, extracts, demonstrating an interaction that is limited to the nucleus, presumably during mitosis. Deletion of the COOH terminus of OPN militated against nuclear localization and Plk-1 interaction. Elevated expression of OPN was also associated with an increase in the number of multinucleate 293 cells, whereas transfection of the COOH-terminal-deleted OPN decreased the percentage of multinucleate cells below basal levels. These findings implicate intranuclear OPN as a participant in the process of cell duplication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005603     DOI: 10.1152/ajpcell.00477.2006

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  29 in total

Review 1.  Intracellular osteopontin (iOPN) and immunity.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

2.  Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence.

Authors:  Gábor Valcz; Ferenc Sipos; Tibor Krenács; Jeannette Molnár; Arpád V Patai; Katalin Leiszter; Kinga Tóth; Norbert Solymosi; Orsolya Galamb; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2010-03-27       Impact factor: 3.201

3.  Natalizumab reduces serum pro-angiogenic activity in MS patients.

Authors:  Pietro Iaffaldano; Domenico Ribatti; Maria Trojano
Journal:  Neurol Sci       Date:  2018-02-13       Impact factor: 3.307

Review 4.  The role of osteopontin in kidney diseases.

Authors:  Beata Kaleta
Journal:  Inflamm Res       Date:  2018-11-19       Impact factor: 4.575

5.  Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.

Authors:  Matthias Bache; Matthias Kappler; Henri Wichmann; Swetlana Rot; Antje Hahnel; Thomas Greither; Harun M Said; Matthias Kotzsch; Peter Würl; Helge Taubert; Dirk Vordermark
Journal:  BMC Cancer       Date:  2010-04-08       Impact factor: 4.430

Review 6.  Oncoprotein metastasis and its suppression revisited.

Authors:  Razvan T Radulescu
Journal:  J Exp Clin Cancer Res       Date:  2010-04-09

7.  Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53.

Authors:  Hyo-Jin Kim; Ho-June Lee; Joon-Il Jun; Yumin Oh; Seon-Guk Choi; Hyunjoo Kim; Chul-Woong Chung; In-Ki Kim; Il-Sun Park; Han-Jung Chae; Hyung-Ryong Kim; Yong-Keun Jung
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-19       Impact factor: 11.205

Review 8.  Regulation of T-helper-cell lineage development by osteopontin: the inside story.

Authors:  Harvey Cantor; Mari L Shinohara
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

9.  Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells.

Authors:  Mari L Shinohara; Hye-Jung Kim; June-Ho Kim; Virgilio A Garcia; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

10.  LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.

Authors:  M E Montañez-Wiscovich; D D Seachrist; M D Landis; J Visvader; B Andersen; R A Keri
Journal:  Oncogene       Date:  2009-08-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.